Plasmid DNA encoding transforming growth factor-β1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model

Journal of Clinical Investigation

Volumn 101, Issue 12, 1998, Pages 2615-2621

  Song, Xiao Yu ^a   Gu, MiLi ^b   Jin, Wen Wen ^a   Klinman, Dennis M ^b   Wahl, Sharon M ^a,c  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b Division of Viral Products   (United States)

^c MSC 4352 ^*  (United States)

Author keywords

Arthritis; Cytokine; Gene therapy; Inflammation immunosuppression

Indexed keywords

CYTOKINE; PLASMID DNA; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; BACTERIAL CELL WALL; CHRONIC DISEASE; CONTROLLED STUDY; FEMALE; GENE TRANSFER; IMMUNOMODULATION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032525893     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2480     Document Type: Article

References (32)

1. Wahl, S.M. 1992. Transforming growth factor beta in inflammation. A cause and a cure. J. Clin. Immunol. 12:1-14.
2. Letterio, J.J., and A.B. Roberts. 1997. TGP-beta: a critical modulator of immune cell function. Clin. Immunol. Immunopathol. 84:244-250.
3. McCartney-Francis, N., and S.M. Wahl. 1994. Transforming growth factor β: a matter of life and death. J. Leukocyte Biol. 55:401-409.
4. Wahl, S.M. 1994. Transforming growth factor β: the good, the bad, and the ugly. J. Exp. Med. 180:1587-1590.
5. Brandes, M.E., J.B. Allen, Y. Ogawa, and S.M. Wahl. 1991. Transforming growth factor β1 suppresses acute and chronic arthritis in experimental animals. J. Clin. Invest. 87:1108-1113.
6. Kuruvilla, A.P., R. Shah, G.M. Hochwald, H.D. Ligitt, M.A. Palladino, and G.J. Thorbecke. 1991. Protective effect for transforming growth factor β1 on experimental autoimmune diseases in mice. Proc. Natl. Acad. Sci. USA. 88: 2918-2921.
7. Racke, M.K., S. Dhib-Jalbut, B. Cannella, P.S. Albert, C.S. Raine, and D.E. McFarlin. 1991. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor β. J. Immunol. 146: 3012-3017.
8. Lefer, A.M., P. Tsao, N. Aoki, and M.A. Palladino, Jr. 1990. Mediation of cardioprotection by transforming growth factor-β. Science. 249:61-64.
9. Kekow, J., D. Reinhold, T. Pap, and S. Ansorge. 1998. Intravenous immunoglobulins and transforming growth factor β. Lancet. 351:184-185.
10. Allen, J.B., C.L. Manthey, A.R. Hand, K. Ohura, L. Ellingsworth, and S.M. Wahl. 1990. Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor β. J. Exp. Med. 171:231-247.
11. Fava, R.N., N.J. Olsen, A.E. Postlethwaite, K.M. Broadley, J.M. Davidson, L.B. Nanney, C. Lucas, and A.S. Townes. 1991. Transforming growth factor β1 (TGF-β1) induced neutrophil recruitment to synovial tissues: implication for TGF-β-driven synovial inflammation and hyperplasia. J. Exp. Med. 173: 1121-1132.
12. Wahl, S.M., J.B. Allen, G.L. Costa, H.L. Wong, and J.R. Dasch. 1993. Reversal of acute and chronic synovial inflammation by anti-transforming growth factor β. J. Exp. Med. 177:225-230.
13. Miller, K.L., J.A. Carlino, Y. Ogawa, P.D. Avis, and K.G. Carroll. 1992. Alterations in erythropoiesis in TGF-beta 1-treated mice. Exp. Hematol. (Charlottesv.). 20:951-956.
14. Border, W.A., and E. Ruoslahti. 1992. Transforming growth factor-beta in disease: the dark side of tissue repair. J. Clin. Invest. 90:1-7.
15. Barr, E., and J.M. Leiden. 1991. Systemic delivery of recombinant proteins by genetically modified myoblasts. Science. 254:1507-1509.
16. Dhawan, J., L.C. Pan, G.K. Pavlath, M.A. Travis, A.M. Lanctot, and H.M. Blau. 1991. Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science. 254:1509-1512.
17. Wolff, J.A., R.W. Malone, P. Williams, W. Chong, G. Acsadi, A. Jani, and P.L. Felgner. 1990. Direct gene transfer into mouse muscle in vivo. Science. 247:1465-1468.
18. Raz, E., A. Watanabe, S.M. Baird, R.A. Eisenberg, T.B. Parr, M. Lotz, T.J. Kipps, and D.A. Carson. 1993. Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc. Natl. Acad. Sci. USA. 90:4523-4527.
19. Quantin, B., L.D. Perricaudet, S. Tajbakhsh, and J.L. Mandel. 1992. Adenovirus as an expression vector in muscle cells in vivo. Proc. Natl. Acad. Sci. USA. 89:2581-2584.
20. Acsadi, G., G. Dickson, D.R. Love, A. Jani, F.S. Walsh, A. Gurusinghe, J.A. Wolff, and K.E. Davies. 1991. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature. 352:815-818.
21. Le, C.H., A.G. Nicolson, A. Morales, and K.L. Sewell. 1997. Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor α receptor gene. Arthritis Rheum. 40: 1662-1669.
22. Hines, K.L., M. Christ, and S.M. Wahl. 1993. Cytokine regulation of the immune response: an in vivo model. Immunomethods. 3: 13-22.
23. Sartor, R.B., H. Herfarth, and E.A.F. Van Tol. 1996. Bacterial cell wall polymer-induced granulomatous inflammation. Methods. 9:233-247.
24. Yocum, D.E., L. Esparza, S. Dubry, J.B. Benjamin, R. Volz, and P. Scuderi. 1989. Characteristics of tumor necrosis factor production in rheumatoid arthritis. Cell. Immunol. 122:131-145.
25. Kopp, J.B., V.M. Factor, M. Mozes, P. Nagy, N. Sanderson, E.P. Bottinger, P.E. Klotman, and S.S. Thorgeirsson. 1996. Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease. Lab. Invest. 74:991-1003.
26. Kozarsky, K.F., and J.M. Wilson. 1993. Gene therapy: adenovirus vectors. Curr. Opin. Genet. Dev. 3:499-503.
27. Nita, I., S.C. Ghivizzani, J. Galea-Lauri, G. Bandara, H.I. Georgescu, P.D. Robbins, and C.H. Evans. 1996. Direct gene delivery to synovium: an evaluation of potential vectors in vitro and in vivo. Arthritis Rheum. 39:820-828.
28. Evans, C.H., and P.D. Robbins. 1994. Prospects for treating arthritis by gene therapy. J. Rheumatol. 21:779-782.
29. Tripathy, S.K., E.C. Svensson, H.B. Black, E. Goldwasser, M. Margalith, P.M. Hobart, and J.M. Leiden. 1996. Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. Proc. Natl. Acad. Sci. USA. 93:10876-10880.
30. Raz, E., J. Dudler, M. Lotz, S.M. Baird, C.C. Berry, R.A. Eisenberg, and D.A. Carson. 1995. Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene therapy. Lupus. 4:286-292.
31. Giladi, E., E. Raz, F. Karmeli, E. Okon, and D. Rachmilewitz. 1995. Transforming growth factor-beta gene therapy ameliorates experimental colitis in rats. Eur. J. Gastroenterol. Hepatol. 7:341-347.
32. Chernajovsky, Y., G. Adama, K. Triantaphyllopoulos, M.F. Ledda, and O.L. Podhajcer. 1997. Pathogenic lymphoid cells engineered to express TGF-β1 ameliorate disease in a collagen-induced arthritis model. Gene Ther. 4:553-559.